SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042987
Filing Date
2019-11-12
Accepted
2019-11-12 16:45:13
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q toca-10q_20190930.htm 10-Q 2014951
2 EX-10.1 toca-ex101_6.htm EX-10.1 114075
3 EX-31.1 toca-ex311_7.htm EX-31.1 9777
4 EX-31.2 toca-ex312_9.htm EX-31.2 9448
5 EX-32.1 toca-ex321_8.htm EX-32.1 6503
  Complete submission text file 0001564590-19-042987.txt   6461032

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT toca-20190930.xml EX-101.INS 1377214
7 XBRL TAXONOMY EXTENSION SCHEMA toca-20190930.xsd EX-101.SCH 39303
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE toca-20190930_cal.xml EX-101.CAL 42429
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE toca-20190930_def.xml EX-101.DEF 138434
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE toca-20190930_lab.xml EX-101.LAB 323716
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE toca-20190930_pre.xml EX-101.PRE 251706
Mailing Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 500 SAN DIEGO CA 92121 (858) 412-8400
Tocagen Inc (Filer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38052 | Film No.: 191210297
SIC: 2834 Pharmaceutical Preparations